Mettler-Toledo International Inc. Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax
Mettler-Toledo International Inc. (MTD) reported Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax of $6.84 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Income Statement › Other Income
us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax · last filed 2023-11-09
- Mettler-Toledo International Inc. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2023-09-30 was $7.74M, a 1.63% increase year-over-year.
- Mettler-Toledo International Inc. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2023-06-30 was -$2.45M, a 142.70% decline year-over-year.
- Mettler-Toledo International Inc. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2022-09-30 was $7.61M, a 512.88% increase year-over-year.
- Mettler-Toledo International Inc. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2022-06-30 was $5.74M.
- Mettler-Toledo International Inc. unrealized gain (loss) on foreign currency derivatives, net, before tax for fiscal 2012 was -$600.00K.
| Period end | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 2 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 3 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 6 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 9 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $7.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.29M derived: sum of 2 quarters · filed 2023-11-09 | $6.84M 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | -$2.45M 10-Q · filed 2023-07-28 | -$895.00K 10-Q · filed 2023-07-28 | |||
| 2022-09-30 | $7.61M 10-Q · filed 2022-11-04 | $13.35M derived: sum of 2 quarters · filed 2023-07-28 | $17.79M 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $5.74M 10-Q · filed 2023-07-28 | $10.18M 10-Q · filed 2023-07-28 | |||
| 2021-09-30 | $1.24M 10-Q · filed 2022-11-04 | -$2.18M derived: sum of 2 quarters · filed 2022-11-04 | $7.00M 10-Q · filed 2022-11-04 | ||
| 2021-06-30 | -$3.42M 10-Q · filed 2022-07-29 | $5.76M 10-Q · filed 2022-07-29 | |||
| 2020-09-30 | -$3.77M 10-Q · filed 2021-11-05 | -$6.33M 10-Q · filed 2021-11-05 | |||
| 2013-03-31 | -$787.00K 10-Q · filed 2013-05-03 | ||||
| 2012-12-31 | -$600.00K 10-K · filed 2013-02-08 | ||||
| 2012-09-30 | -$600.00K 10-Q · filed 2012-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |